AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2011-09-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 568
- Registration Number
- NCT00698932
- Locations
- 🇵🇭
Research Site, Quezon City, Philippines
Single and Multiple Ascending Doses of AZD1981 in Japan
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: AZD1981Drug: Placebo
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2010-12-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 47
- Registration Number
- NCT00698282
- Locations
- 🇬🇧
Research Site, Berkshire, United Kingdom
Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study
Completed
- Conditions
- GERD
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2009-02-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 300
- Registration Number
- NCT00697008
- Locations
- 🇪🇸
Research Site, Zaragoza, Spain
AZD2624 Multiple Ascending Dose Study in Japan
Phase 1
Completed
- Conditions
- HealthySafety
- Interventions
- Drug: AZD2624Drug: Placebo
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2009-07-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT00696865
- Locations
- 🇯🇵
Research Site, Kanagawa, Japan
National Survey on Gastroesophageal Reflux Disease (GERD) Patients
Completed
- Conditions
- GERD
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 5084
- Registration Number
- NCT00695838
- Locations
- 🇫🇷
Research Site, Yvre L Eveque, France
National Survey on Infiltrative Breast Cancer
Completed
- Conditions
- Infiltrative Breast Cancer
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1500
- Registration Number
- NCT00696527
- Locations
- 🇫🇷
Research Site, Villejuif Cedex, France
National Survey on Hypertension in General Practitioner (GP) Consultation
Completed
- Conditions
- Hypertension
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2853
- Registration Number
- NCT00695656
- Locations
- 🇫🇷
Research Site, Zuydcoote, France
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
Completed
- Conditions
- Hypercholesterolaemia
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2009-10-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 810
- Registration Number
- NCT00695539
- Locations
- 🇬🇷
Research Site, Thessaloniki, Greece
National Survey on Hypertension at Hospital
Completed
- Conditions
- Hypertension
- First Posted Date
- 2008-06-11
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 655
- Registration Number
- NCT00695266
- Locations
- 🇫🇷
Research Site, Villeneuve St Georges Cedex, France
Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
Completed
- Conditions
- New StrategiesGINA 2006Patient Opinion
- First Posted Date
- 2008-06-11
- Last Posted Date
- 2009-04-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 832
- Registration Number
- NCT00695357
- Locations
- 🇬🇷
Research Site, Xalkida, Greece
© Copyright 2025. All Rights Reserved by MedPath